Showing results (471-480 of 537) with videos related to
Sort By:
Pageof 54
American Heart Journal|December 11, 2017
Durability of quality of life benefits of transcatheter aortic valve replacement: Long-term results from the CoreValve US extreme risk trialSuzanne J Baron, Suzanne V Arnold, Matthew R Reynolds, et al.Journal of the American College of Cardiology|May 21, 2016
Impact of Ejection Fraction and Aortic Valve Gradient on Outcomes of Transcatheter Aortic Valve ReplacementSuzanne J Baron, Suzanne V Arnold, Howard C Herrmann, et al.Journal of the American Heart Association|September 28, 2021
Temporal Changes in Mortality After Transcatheter and Surgical Aortic Valve Replacement: Retrospective Analysis of US Medicare Patients (2012-2019)Sandra B Lauck, Suzanne J Baron, William Irish, et al.Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|July 1, 1995
Inhalant allergen-specific T-cell reactivity is detectable in close to 100% of atopic and normal individuals: covert responses are unmasked by serum-free mediumJ W Upham, B J Holt, M J Baron-Hay, et al.JAMA Cardiology|February 2, 2017
Quality-of-Life Outcomes After Transcatheter Aortic Valve Replacement in an Unselected Population: A Report From the STS/ACC Transcatheter Valve Therapy RegistrySuzanne V Arnold, John A Spertus, Sreekanth Vemulapalli, et al.The American Journal of Cardiology|April 6, 2024
Immediate Versus Staged Complete Revascularization in Patients With Acute Coronary Syndrome: A Systematic Review and Meta-Analysis of Randomized Controlled TrialsHuzaifa Ahmad Cheema, Karan Bhanushali, Aruba Sohail, et al.Mayo Clinic Proceedings|July 5, 2021
Sex Differences in Outcomes Following Left Atrial Appendage ClosureShubrandu S Sanjoy, Yun-Hee Choi, Robert T Sparrow, et al.Structure (London, England : 1993)|March 15, 2006
Structural basis of RNA binding discrimination between bacteriophages Qbeta and MS2Wilf T Horn, Kaspars Tars, Elin Grahn, et al.Circulation|February 21, 2020
Cost-Effectiveness of Tafamidis Therapy for Transthyretin Amyloid CardiomyopathyDhruv S Kazi, Brandon K Bellows, Suzanne J Baron, et al.Current Problems in Cardiology|February 24, 2023
Real-World Efficacy of Tafamidis in Patients With Transthyretin Amyloidosis and Heart FailureAhmed Ghoneem, Ammar W Bhatti, Sumanth Khadke, et al.Pageof 54